SARDI, IACOPO
 Distribuzione geografica
Continente #
NA - Nord America 1.261
EU - Europa 818
AS - Asia 205
AF - Africa 3
SA - Sud America 1
Totale 2.288
Nazione #
US - Stati Uniti d'America 1.257
PL - Polonia 294
IE - Irlanda 131
SE - Svezia 128
IT - Italia 75
HK - Hong Kong 74
CN - Cina 46
UA - Ucraina 43
DE - Germania 37
SG - Singapore 29
FI - Finlandia 28
GB - Regno Unito 22
JO - Giordania 21
BE - Belgio 18
CH - Svizzera 14
IN - India 14
RU - Federazione Russa 14
VN - Vietnam 10
FR - Francia 7
TR - Turchia 5
CA - Canada 4
KR - Corea 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
GR - Grecia 2
NL - Olanda 2
BR - Brasile 1
GE - Georgia 1
RO - Romania 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 2.288
Città #
Warsaw 294
Fairfield 164
Chandler 159
Dublin 131
Woodbridge 90
Ashburn 87
Ann Arbor 81
Jacksonville 71
Cambridge 70
Seattle 67
Houston 60
Wilmington 50
Hong Kong 42
Princeton 33
Boston 29
Kent 22
Buffalo 21
Florence 21
Boardman 20
Shanghai 19
Brussels 18
Beijing 15
Singapore 15
Altamura 14
Bern 14
Lawrence 14
San Diego 11
Medford 10
Dong Ket 8
Falls Church 7
Pune 7
London 4
Los Angeles 4
Milan 4
New York 4
Bremen 3
Phoenix 3
Seoul 3
Toronto 3
Andover 2
Auburn Hills 2
Dearborn 2
Douala 2
Fontebuona 2
Grugliasco 2
Guangzhou 2
Heraklion 2
Moscow 2
Munich 2
Norwalk 2
Padova 2
Rheinfelden 2
Santa Clara 2
Toano 2
Zaozhuang 2
Zavidovici 2
Americana 1
Amsterdam 1
Arezzo 1
Brooklyn 1
City of Westminster 1
Deiva Marina 1
Düsseldorf 1
Frankfurt Am Main 1
Grafing 1
Gurgaon 1
Helsinki 1
Izmir 1
Kilburn 1
Lappeenranta 1
Mountain View 1
Noida 1
Old Bridge 1
Ottawa 1
Redwood City 1
Rufina 1
San Casciano in Val di Pesa 1
San Mateo 1
San Miniato Basso 1
Shenzhen 1
Verona 1
Totale 1.751
Nome #
Lipid peroxidation and cyclooxygenase-2 activity in human hepatocellular carcinoma cell lines with and without multiple drug resistance: correlation with cell growth 177
Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma 177
Aldoxorubicin and Temozolomide combination in a xenograft mice model of human glioblastoma. 137
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer 110
A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation 110
Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. 103
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. 103
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 95
Pineal germinoma morphological features in a liquid-based cerebrospinal fluid sample 92
The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR. 90
Microsatellite alterations in superficial and locally advanced transitional cell carcinoma of the bladder 85
Molecular detection of microsatellite instability in basal cell carcinoma. 85
Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. 79
Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series 72
GENE-03. MICRORNAS PROFILE IN PAEDIATRIC GBMS 72
PHARMACOLOGICAL MODULATION OF BLOOD-BRAIN BARRIER: FUTURE STRATEGY FOR TREATMENT OF BRAIN TUMORS 64
Microsatellite instability as marker of cancer progression in preinvasive laryngeal cancer 56
The multiple drug resistence phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. 52
Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene? 50
O6-Methylguanine-DNA-methyltransferase in recurring anaplastic ependymomas: PCR and immunohistochemistry. J Chemother 48
Primary cerebral myxofibrosarcoma: clinical, morphologic, immunohistochemical, molecular, and ultrastructural study of an infrequent tumor in an extraordinary localization. 45
. Cyclooxygenase-2 and vascular endothelial growth factor expression in human colorectal cancer: implication for tumor angiogenesis 42
The use of microsatellites as markers of neoplastic progression in head and neck carcinoma 39
Espressione della cicloossigenasi-2 e produzione di prostaglandina E2 nel carcinoma colorettale: correlazione con lo stadio ed il grado di angiogenesi tumorale. 36
The proangiogenic effect of nitric oxide is mediated by COX-2 activity in colorectal cancer. 34
Coexpression of inducible nitric oxide synthase and cyclooxygenase-2 in human colorectal cancer: possible involvement in tumor angiogenesis 32
Microsatellite alterations as clonal markers for the detection of cancer cells possible role in predicting tumor molteplicity risk in head and neck squamous cell carcinoma 28
Valutazione el rischio di molteplicità tumorale in pazienti con carcinoma squamocellulare del distretto testa-collo attraverso l'analisi dei microsatelliti. 27
Overexpression of nitric oxide synthase correlates with tumor angiogenesis and cancer growth in human colorectal cancer 26
Prediction of recurrence by microsatellite analyses in head and neck cancer 25
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 24
Hippo Pathway in Regulating Drug Resistance of Glioblastoma 23
Regulation of ciclooxygenase-2 pathway in human carcinoma cells by nitric oxide. Possible effects on VEGF-induced Tumor angiogenesis 22
Diencephalic syndrome in childhood, a challenging cause of failure to thrive: miniseries and literature review 17
Brief report: pediatric high-grade gliomas treated with vinorelbine and valproic acid added to temozolomide 17
Robot-assisted transcerebellar stereotactic approach to the posterior fossa in pediatric patients: a technical note 14
Genetic signature and treatment of pediatric high-grade glioma 11
Totale 2.319
Categoria #
all - tutte 7.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020481 27 43 14 36 50 67 54 65 47 27 41 10
2020/2021374 26 27 22 33 27 45 29 41 34 46 19 25
2021/2022197 7 17 1 10 7 11 1 15 9 11 41 67
2022/2023618 55 65 34 41 55 126 81 43 77 5 17 19
2023/2024265 5 31 47 10 24 41 14 48 2 4 28 11
2024/202542 42 0 0 0 0 0 0 0 0 0 0 0
Totale 2.319